EGR1 and neoplasm: DNAzyme (a 33-nucleotide ssDNA) was particularly designed with sequence in complementary to part of target EGR-1 mRNA, which generally exists in the cytoplasm of normal cells but over-expressed in MCF-7 human breast cancer cells35–37.